AlivaMab Biologics Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
AlivaMab Biologics provides integrated biologics drug discovery solutions via a configurable platform of capability modules. The modules span target validation, protein and cell-based tool engineering and production, functional assay development, and discovery and characterization of binding domains, alongside developability assessment and optimization, across multiple biologic modalities. Clients can select a full suite or individual modules to tailor their discovery and development program, with an emphasis on speed and risk reduction. The company is based in San Diego, California, and operates as a small to mid-sized biotechnology firm serving pharmaceutical and biotech partners. Recent developments include the appointment of Ankita Srivastava as Vice President of Antibody Engineering and Protein Sciences in April 2023, reflecting its ongoing growth and leadership in the field.